Real-time enrollment status for this recurrent high grade glioma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:19 PM UTC
| NCT Number | NCT06126744 |
| Recruiting Status | Recruiting |
| Condition | Recurrent High Grade Glioma |
| Phase | PHASE1 |
| Target Enrollment | 51 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Duke University |
| Last Updated on CT.gov | April 15, 2026 (Apr 15, 2026) |
As of July 17, 2026: Clinical trial NCT06126744 is currently recruiting participants. This phase1 study for recurrent high grade glioma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Duke University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06126744 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06126744 was last updated Apr 15, 2026 (April 15, 2026). HelloStudys verifies this status automatically.